TrialThe Lancet. Child & adolescent health2025

Immunogenicity and safety of a measles and rubella-containing vaccine at age 6 and 9 months in Bangladesh: an open-label, randomised trial.

Takudzwa S Sayi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.